@article{40125df94db844c486c4b09fad2aa8f6,
title = "Hospital-based use of thromboprophylaxis in patients with COVID-19",
author = "Spyropoulos, {Alex C.} and Walter Ageno and Barnathan, {Elliot S.}",
note = "Funding Information: ACS has received grants or research support from Janssen and Boehringer Ingelheim; has received fees for consulting from Janssen, Bayer Healthcare, and Boehringer Ingelheim; has been on the advisory board for Janssen, Boehringer Ingelheim, Portola, Bayer Healthcare, and Daiichi Sankyo; and has received stipends from ATLAS, an Academic Research Organization. WA has received grants and research support from Bayer Healthcare and has received fees for consulting from Janssen, Bayer Healthcare, Portola, Daiichi Sankyo, Aspen, Bristol-Myers Squibb, Pfizer, Boehringer Ingelheim, and Sanofi. ESB is an employee and stockholder of Johnson and Johnson and is an inventor on a patent.",
year = "2020",
month = may,
day = "2",
doi = "10.1016/S0140-6736(20)30926-0",
language = "English",
volume = "395",
pages = "e75",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier B.V.",
number = "10234",
}